Last reviewed: October 2026 · Cleared Peptides research team
Lixisenatide is an exendin-4-based peptide listed under CAS 320367-13-3. Public synonyms include ZP10. It is described in receptor literature as a GLP-1 receptor agonist. The sequence is an exendin-4 derivative extended with C-terminal lysines. This page does not reprint a residue-by-residue sequence; a lot COA would be the sequence record if a lot existed.
| Name | Lixisenatide |
|---|---|
| Other names | ZP10; ZP10A |
| CAS number | 320367-13-3 |
| Class | Exendin-4-based GLP-1 receptor peptide |
| Catalog status | Not a current Cleared Peptides lot. |
Related guides
See exenatide for synthetic exendin-4 without that lysine extension, and semaglutide for an acylated GLP-1 analog.
Frequently Asked Questions
What is the CAS number?
320367-13-3.
Is lixisenatide a dual or triple agonist?
Public descriptions place it at the GLP-1 receptor. This page does not assign GIP or glucagon receptor activity to it.
Is this for human use?
No. Laboratory reference only.
Selected References
Registry records and peer-reviewed literature listed as scientific background. Citation does not imply endorsement, a benefit, or any use.
- Public compound record for CAS 320367-13-3, retrieved under the name lixisenatide. Cited as the identity record.
Research Use Only Notice
This guide is provided for educational and laboratory reference purposes. It summarizes published structural and biochemical literature. It does not describe, recommend, or imply any use in humans or animals. These materials are not drugs, foods, cosmetics, or dietary supplements on this page, are not offered here as a treatment, and no dosing or administration instructions are provided. Cleared Peptides does not currently list a lot for every compound on this page.
